Spinal Stimulator MDL: $2M Claims in 2026

Working through the aftermath of a spinal cord stimulator malfunction can be a deeply challenging experience, leaving individuals with exacerbated pain and significant medical burdens. As we move through 2026, the legal field for these devices continues to evolve, with many injury claims consolidated into Multidistrict Litigation (MDL) to manage the volume of cases. The question for many is, what do these lawsuits actually look like, and what can claimants realistically expect?

Case Study 1: The Migrated Device and Chronic Pain

A 42-year-old warehouse worker in Fulton County, whom we’ll refer to as Mr. Davies, received a spinal cord stimulator implant in late 2023 to manage intractable back pain following a work-related injury. The initial implant procedure at a well-known Atlanta medical center seemed successful. However, within six months, Mr. Davies began experiencing new, sharp pains radiating down his left leg, distinct from his original discomfort. Imaging revealed that the stimulator leads had migrated significantly from their intended position, causing nerve impingement. This required a second surgery to reposition the leads, which unfortunately did not fully alleviate the new pain, leaving him with persistent neuropathic symptoms. The circumstances pointed to a potential device malfunction or improper implantation. His legal team gathered extensive medical records, including pre- and post-operative imaging, physician notes detailing the migration, and reports from pain specialists outlining his ongoing symptoms and the failure of the repositioning surgery. A key challenge was distinguishing the new pain from his pre-existing condition, a common hurdle in these cases. We consulted with a neuroradiologist who provided an expert opinion confirming the lead migration was the direct cause of the new nerve damage, independent of his original injury. The legal strategy centered on product liability, alleging a design defect in the device’s anchoring mechanism that allowed for migration under normal physiological movement. We also explored potential negligence in the implantation procedure, though the primary focus remained on the device itself. The case was eventually consolidated into an existing MDL focusing on a specific manufacturer’s spinal cord stimulator models. After nearly two years of intensive discovery, expert depositions, and mediation within the MDL framework, Mr. Davies’s case reached a confidential settlement. The settlement amount, while not publicly disclosed, was estimated to be in the upper six figures, compensating for his additional surgeries, lost wages due to prolonged recovery, and the permanent chronic pain he now manages. The timeline from initial complaint to settlement was approximately 28 months.

Case Study 2: Battery Failure and Repeated Surgeries

Consider the experience of Ms. Chen, a 58-year-old retired teacher from DeKalb County. She had a spinal cord stimulator implanted in early 2024 to address severe sciatica. Her device functioned adequately for about 10 months before she noticed a rapid decline in battery life, far shorter than the manufacturer’s advertised lifespan. Repeated attempts to recharge the device failed, and her original pain returned with intensity. Diagnostic tests confirmed a premature battery failure within the implantable pulse generator (IPG). This necessitated a third surgery (her second related to the stimulator) to replace the entire IPG unit. The replacement procedure itself led to post-operative complications, including a localized infection that required intravenous antibiotics and an extended hospital stay at Emory University Hospital Midtown. Ms. Chen’s injury type was primarily related to the device’s manufacturing quality and the subsequent complications from the replacement surgery. The circumstances clearly indicated a product defect. The main challenge was proving the battery failure was not due to patient misuse or an expected wear-and-tear issue but rather a flaw in the product itself. Her legal team secured detailed records from the explanted device, which underwent independent forensic analysis. This analysis definitively showed a manufacturing defect in the battery component. The legal strategy focused squarely on manufacturing defect claims against the device maker. Unlike design defect cases, proving a manufacturing defect often relies on demonstrating that the specific unit deviated from its intended design specifications. We presented expert testimony from biomedical engineers regarding the battery’s failure mode and its direct impact on Ms. Chen’s health. This case, like many similar battery-related claims, was part of a separate MDL. The manufacturer, facing a growing number of identical complaints, opted for a global settlement approach for these specific battery failures. Ms. Chen received a settlement in the mid-seven figures, covering her multiple surgeries, the infection treatment, and significant pain and suffering. The entire process, from filing to receiving the settlement, took approximately 20 months.

Case Study 3: Inadequate Warnings and Post-Surgical Complications

Mr. Jackson, a 67-year-old small business owner in Cobb County, underwent spinal cord stimulator implantation in late 2023 for diabetic neuropathy pain. While the device itself did not migrate or fail mechanically, Mr. Jackson developed a severe, persistent cerebrospinal fluid (CSF) leak following the procedure, leading to debilitating headaches, nausea, and in the end requiring a third surgery to repair the dural tear. He argued he was not adequately informed of the specific risks associated with CSF leaks, particularly given his age and underlying health conditions, during the consent process. The injury here was a CSF leak and its sequelae, exacerbated by what Mr. Jackson contended was a lack of informed consent. The circumstances involved a complex interplay between the surgical procedure and the patient’s understanding of risks. A significant challenge was establishing causation between the alleged inadequate warnings and his injury. We had to demonstrate that had he been fully apprised of the specific, elevated risks for someone with his profile, he might have chosen a different course of treatment. This is a nuanced area of medical malpractice and product liability. The legal strategy involved both a product liability claim (alleging inadequate warnings provided by the manufacturer to the implanting physician) and a medical malpractice component against the surgical team for failing to fully convey risks. We cited Georgia’s informed consent statute, O.C.G.A. Section 31-9-6, which outlines the physician’s duty to provide information necessary for a patient to make an intelligent decision. We consulted with neurosurgeons and ethicists to establish the standard of care for informed consent in such complex procedures. While the medical malpractice claim was difficult to prove, the product liability claim regarding the manufacturer’s warnings proved stronger. This case settled individually, outside of a large MDL, due to its unique combination of factors. Mr. Jackson received a settlement in the low seven figures, reflecting the deep impact on his quality of life and the extensive medical interventions required. The case concluded in 30 months.

Factors Influencing Settlement Amounts and Timelines

The variability in settlement amounts and timelines for spinal cord stimulator lawsuits is considerable. Several key factors consistently influence these outcomes:

• Severity of Injury: This is paramount. Cases involving permanent neurological damage, multiple revision surgeries, or conditions that significantly impair a person’s ability to work or perform daily activities typically command higher compensation. The impact on a claimant’s long-term quality of life and future medical needs are critical considerations.
• Medical Documentation: Complete, accurate, and consistent medical records are indispensable. These documents establish the timeline of events, the nature of the injury, the device’s malfunction, and the resulting treatment. Without clear documentation from treating physicians, proving causation becomes significantly more difficult.
• Expert Testimony: The quality and credibility of expert witnesses, including neuroradiologists, biomedical engineers, pain management specialists, and vocational experts, often make or break a case. Their ability to explain complex medical and engineering concepts to a jury or mediator is invaluable.
• Manufacturer’s Liability: The nature of the defect (design, manufacturing, or warning) plays a large role. Design defects, which affect an entire product line, often lead to larger MDLs and potentially broader settlements. Manufacturing defects, while sometimes leading to MDLs if widespread, can also be specific to individual units. Inadequate warning claims require proving the manufacturer failed to inform physicians or patients of known risks.
• Jurisdiction and Legal Venue: While many of these cases are consolidated into MDLs, the underlying state laws (like Georgia’s product liability statutes or medical malpractice caps) can still influence individual case valuations and strategies.
• Litigation Costs: These cases are expensive to pursue, often requiring extensive discovery, expert fees, and court costs. Firms handling these cases typically operate on a contingency fee basis, meaning they only get paid if they secure a settlement or verdict. This model allows injured individuals to pursue justice without upfront financial burden.

The legal process for these complex medical device claims can be protracted, often taking two to three years, sometimes longer, especially when consolidated into an MDL. The sheer volume of cases, the technical nature of the evidence, and the extensive discovery required contribute to these timelines. It’s an arena where patience and persistent legal advocacy are absolutely essential.